Biogen (BIIB) EBT (2009 - 2026)
Biogen's EBT came in at $132.4 million for Q2 2026, down 82.2% from $744 million a year earlier and down 64.9% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) EBT (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Biogen reported EBT of $1.01 billion, down 43.7% year-over-year; for FY2025, it came in at $1.56 billion, down 18.3% from FY2024.
- EBT carries a five-year compound annual growth rate of -21.0% (FY2020 to FY2025).
- Going back by year, EBT was $1.91 billion in FY2024 (+47.0%), $1.3 billion in FY2023 (-63.9%), $3.59 billion in FY2022 (+105.8%) and $1.75 billion in FY2021 (-65.4%).
- The five-year range for quarterly EBT is -$141.2 million (Q3 2023) to $1.37 billion (Q3 2022).
- Year-over-year, EBT increased in three of the last six quarters, with an average decline of 10.6%.
- The fastest year-over-year change in EBT over five years came in Q3 2022 (growth of 371.0%), and the weakest in Q2 2026 (a decline of 82.2%).
- Business Quant data shows BIIB's EBT at $377.7 million (Q1 2026), -$56 million (Q4 2025) and $557.3 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.39 Bn |
| 10 | Biogen | 33.37 Bn | 20.03 Bn | 1.96 Bn | 132.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 132.40 Mn |
| Mar 31, 2026 | 377.70 Mn |
| Dec 31, 2025 | -56.00 Mn |
| Sep 30, 2025 | 557.30 Mn |
| Jun 30, 2025 | 744.00 Mn |
| Mar 31, 2025 | 311.20 Mn |
| Dec 31, 2024 | 291.50 Mn |
| Sep 30, 2024 | 451.00 Mn |
| Jun 30, 2024 | 698.70 Mn |
| Mar 31, 2024 | 464.80 Mn |
| Dec 31, 2023 | 291.60 Mn |
| Sep 30, 2023 | -141.20 Mn |
| Jun 30, 2023 | 708.10 Mn |
| Mar 31, 2023 | 438.30 Mn |
| Dec 31, 2022 | 603.80 Mn |
| Sep 30, 2022 | 1.37 Bn |
| Jun 30, 2022 | 1.27 Bn |
| Mar 31, 2022 | 347.40 Mn |
| Dec 31, 2021 | 405.00 Mn |
| Sep 30, 2021 | 291.10 Mn |
API Access
Biogen EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();